Dual Recognition For TERANODE XDA's Contributions To LIMS And Bioinformatics Markets

PALO ALTO, Calif., Sept. 19 /PRNewswire/ -- Frost & Sullivan is proud to present Teranode Corporation with the 2005 Awards for Technology Innovation as well as Technology Leadership for its TERANODE XDA. The awards recognize the company's contribution through its experiment design automation (XDA) software to the U.S. laboratory information management systems (LIMS) and bioinformatics markets.

Each year, Frost & Sullivan gives the Technology Innovation Award to a company that has demonstrated technological superiority within its industry, successfully developing and introducing a new technology that has created a well-designed product family. Teranode wins the award this year for its success in the LIMS market in 2004.

Teranode wins its second award for its contribution to bioinformatics through TERANODE XDA's data analysis capabilities. Each year, Frost & Sullivan presents the Technology Leadership Award to a company that has pioneered the development and introduction of an innovative technology into the market that has either impacted or has the potential to impact several market sectors.

Teranode is the first to launch a model-driven LIMS for the life sciences industry -- a tool that has been incorporated in the latest version of the company's XDA platform.

"A model-driven approach in a life science setting allows laboratories to automate experiments without any programming," says Frost & Sullivan Research Analyst Jessica Shah. "Besides reducing product development costs, this improves the quality of informatics by providing affordable LIMS solutions to customers."

Teranode has already secured customers such as Pfizer Inc., Amgen Inc., and GlaxoSmithKline. Teranode's proven track record has helped the company carry out successful pilot tests with site- to enterprise-wide installations. Recently, the company became a member of the World Wide Web Consortium (W3C) with the intent to expand LIMS capabilities into Semantic Web technology. The integration of LIMS with this technology will further strengthen data accessibility and mobility.

These capabilities add to the XDA platform's primary aim of integrating computational chemistry and biology with lab data to maximize the value of physical experiments and accelerate research. The platform provides a productivity tool for scientists to visually link experimental protocols to biological systems data in order to optimize experimental parameters, select high probability targets, and accelerate analysis.

"TERANODE XDA is empowering scientists to design high-value experiments, capture and analyze results, and collaborate across labs using one solution," says Joe Duncan, CEO of Teranode. "Our platform eliminates the common challenge of fragmented data management and access by providing a repository for data integration and project collaboration throughout the discovery and development cycle for the benefit of accelerated R&D."

A major significance of Teranode's products lays in their ability to scale transparently from individual informatics and workgroup informatics, to enterprise informatics. The company bases its products upon a specialized modeling and data integration language that automates semantic indexing and computation.

Teranode was one of the first bioinformatics companies to offer the ability to combine experimental and computational biology in a single solution. In recognition of its development of industry-leading bioinformatics platforms, which are not only innovative but also have exceptional design elegance, capacity, and are easy to use, Teranode is the deserving recipient of the two Frost and Sullivan awards for Technology Innovation and Leadership.

About Teranode

Teranode Corporation, a venture-backed company headquartered in Seattle, Washington, is the leading innovator of experiment design automation (XDA) software that integrates in-silico and lab experimentation. Teranode's award-winning products are used by leading pharmaceutical, biotechnology, research and academic organizations, including Pfizer, AstraZeneca, NIH Chemical Genomics Center, MIT, and Fred Hutchinson Cancer Research Center, to improve the speed and value of experimentation in R&D and then share chemical and biological knowledge enterprise-wide. For more information, visit http://www.teranode.com .

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com .

Contact: Stacie Jones 210.247.2450 Stacie.jones@frost.com

Frost & Sullivan

CONTACT: Stacie Jones of Frost & Sullivan, +1-210-247-2450, orStacie.jones@frost.com

Back to news